DrugPatentWatch Database Preview

Hoffmann La Roche Company Profile

« Back to Dashboard

What is the competitive landscape for HOFFMANN LA ROCHE, and when can generic versions of HOFFMANN LA ROCHE drugs launch?

HOFFMANN LA ROCHE has thirteen approved drugs.

There are thirteen US patents protecting HOFFMANN LA ROCHE drugs.

There are three hundred and forty-seven patent family members on HOFFMANN LA ROCHE drugs in fifty-two countries and twenty-eight supplementary protection certificates in fifteen countries.

Summary for Hoffmann La Roche

International Patents:	347
US Patents:	13
Tradenames:	11
Ingredients:	10
NDAs:	13

Drugs and US Patents for Hoffmann La Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hoffmann La Roche	ZELBORAF	vemurafenib	TABLET;ORAL	202429-001	Aug 17, 2011		RX	Yes	Yes
Hoffmann La Roche	BONIVA	ibandronate sodium	TABLET;ORAL	021455-002	Mar 24, 2005	AB	RX	Yes	Yes	7,192,938
Hoffmann La Roche	ROCEPHIN	ceftriaxone sodium	INJECTABLE;INJECTION	063239-003	Aug 13, 1993		DISCN	No	No

Expired US Patents for Hoffmann La Roche

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hoffmann La Roche	XELODA	capecitabine	TABLET;ORAL	020896-001	Apr 30, 1998	4,966,891
Hoffmann La Roche	VALCYTE	valganciclovir hydrochloride	TABLET;ORAL	021304-001	Mar 29, 2001	6,083,953*PED
Hoffmann La Roche	ACCUTANE	isotretinoin	CAPSULE;ORAL	018662-003	May 7, 1982	4,322,438

Paragraph IV (Patent) Challenges for HOFFMANN LA ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	For Oral Solution	50 mg/mL		2011-03-21
	Tablets	2.5 mg and 150 mg		2007-05-16
	Tablets	450 mg		2005-12-27
	Injection	1 mg/mL, 3 mL Vial		2007-08-31
	Tablets	150 mg and 500 mg		2008-11-10

Premature patent expirations for HOFFMANN LA ROCHE

Expiration due to failure to pay maintenance fee

Patent Number	Expiration Date

International Patents for Hoffmann La Roche Drugs

Country	Patent Number	Estimated Expiration
Brazil	PI0611863
Serbia	52457
Hong Kong	1217195

Supplementary Protection Certificates for Hoffmann La Roche Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1893612	2012C/028	Belgium		PRODUCT NAME: VERMURAFENIB ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, SOUS TOUTES FORMES COUVERTES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/12/751/001 20120221
1893612	PA2012010	Lithuania		PRODUCT NAME: VEMURAFENIBUM; REGISTRATION NO/DATE: EU/1/12/751/001 20120217
1893612	122, 5012-2012	Slovakia		PRODUCT NAME: VEMURAFENIB; REGISTRATION NO/DATE: EI/1/712/751/002 20120217

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Hoffmann La Roche
• Hoffmann-la Roche